These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1035518)

  • 1. [Determination of blood prolactin levels in breast diseases using prolactin radioimmunoassay kits (CIS-Prolak Kit)].
    Nakajima K; Saito K; Tobioka M; Ishihara K; Kobayashi T
    Horumon To Rinsho; 1976 Dec; 24(12):1303-10. PubMed ID: 1035518
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prolactin. Radioimmunoassay in female breast cancers and benign mastopathies].
    Gorins A; Netter A
    Nouv Presse Med; 1974 Jan; 3(2):73-5. PubMed ID: 4815434
    [No Abstract]   [Full Text] [Related]  

  • 3. [L-dopa and prolactin in breast neoplasms and dysplasia].
    Moguilevsky L; Scacchi P; Szwarcfarb B; Barbarelli J; Moguilevsky JA
    Medicina (B Aires); 1978; 38(1):27-30. PubMed ID: 713825
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum prolactin level in healthy women and patients with functional disorders of the breast].
    Ozieblo L
    Endokrynol Pol; 1977; 28(4):323-30. PubMed ID: 891477
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pituitary hormone level in breast cancer patients].
    Agranat VZ; Valiura AV; Nikogosian GA
    Med Radiol (Mosk); 1981 Mar; 26(3):3-8. PubMed ID: 6783807
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma prolactin in breast cancer.
    Boyns AR; Cole EN; Griffiths K; Roberts MM; Buchan R; Wilson RG; Forrest AP
    Eur J Cancer (1965); 1973 Feb; 9(2):99-102. PubMed ID: 4717492
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Prolactin in benign and malignant breast disease.
    Cole EN; England PC; Sellwood RA; Griffiths K
    J Endocrinol; 1976 Jun; 69(3):49P-50P. PubMed ID: 950543
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
    England PC; Sellwood RA; Knyba RE; Irvine JD
    Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship of plasma prolactin to 17-B oestradiol in women with tumours of the breast.
    Jones MK; Ramsay ID; Collins WP; Dyer GI
    Eur J Cancer (1965); 1977 Oct; 13(10):1109-12. PubMed ID: 923610
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum prolactin concentrations in benign breast disease throughout the menstrual cycle.
    Cole EN; Sellwood RA; England PC; Griffiths K
    Eur J Cancer (1965); 1977 Jun; 13(6):597-603. PubMed ID: 880967
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood prolactin level of breast and endometrial cancer patients during surgical intervention].
    Pozdniakov VV; Bobrov IuF; Gamaiunova VB; Evtiukhin AI; Frid IA
    Vopr Onkol; 1984; 30(2):9-14. PubMed ID: 6702135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian variation of serum prolactin and TSH of women in health or with mammary carcinoma, fibroadenoma or fibrocystic mastopathy.
    Tarquini B; Gheri R; Romano S; Costa A; Cagnoni M; Lee JK; Halberg F
    Int J Chronobiol; 1980; 7(2):101-15. PubMed ID: 7450919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Letter: Prolactin and breast cancer].
    Rolandi E; Barreca T; Masturzo P; Polleri A; Indiveri F; Barabino A
    Nouv Presse Med; 1974 Dec; 3(45):2743. PubMed ID: 4459869
    [No Abstract]   [Full Text] [Related]  

  • 14. Circadian mesor-hyperprolactinemia in fibrocystic mastopathy.
    Tarquini B; Gheri R; Romano S; Costa A; Cagnoni M; Lee JK; Halberg F
    Am J Med; 1979 Feb; 66(2):229-37. PubMed ID: 425966
    [No Abstract]   [Full Text] [Related]  

  • 15. [Possibility of using tumor markers, pituitary gonadotropic hormones and prolactin in the diagnosis of breast cancer].
    Korolev VI; Skliar SIu; Chebotareva ED; Akimova RN
    Vopr Onkol; 1986; 32(11):55-9. PubMed ID: 3788082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammary cancer risk: circulating TSH and prolactin, fibrocystic breast disease in chronoepidemiologic perspective.
    Tarquini B; Benvenuti M; Legnaioli M; Bazzani M; Cagnoni M; Halberg F
    Cancer Detect Prev; 1981; 4(1-4):525-34. PubMed ID: 7349819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prolactin in serum and anamnestic data of women with cystic disease of the breast (author's transl)].
    Bischoff J; Rebhan EM; Prestele H; Becker H
    Geburtshilfe Frauenheilkd; 1980 Jan; 40(1):65-71. PubMed ID: 7353778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of plasma prolactin in patients with breast dysplasia].
    Vázquez Albaladejo C; Ferrer S; Merle S; Sanchis V; Camps Roig J; Giménez Climent J
    Rev Esp Oncol; 1983; 30(3):323-36. PubMed ID: 6571376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma prolactin in women with mastodynia.
    Graziottin A; Sopracordevole F; Velasco M; Grella PV
    Clin Exp Obstet Gynecol; 1984; 11(3):113-6. PubMed ID: 6539179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma-prolactin in human breast cancer.
    Kwa HG; De Jong-Bakker M; Engelsman E; Cleton FJ
    Lancet; 1974 Mar; 1(7855):433-5. PubMed ID: 4131433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.